© 2023 MJH Life Sciences and Patient Care Online. All rights reserved.
© 2023 MJH Life Sciences™ and Patient Care Online. All rights reserved.
January 27, 2023
The FDA wants clinicians to avoid using the neutralizing antibody as it appears to be less effective against newer circulating strains of the SARS-CoV-2 virus.
August 23, 2022
Pfizer-BioNTech filed with the FDA for emergency use authorization of a 30-mcg dose of an Omicron BA.4.BA.5-adapted vaccine for those aged ≥12 years.